141 related articles for article (PubMed ID: 29802079)
1. Mortality from Parkinson's disease in China: Findings from a ten-year follow up study in Shanghai.
Zhang Y; Wang C; Wang Y; Xiao Q; Liu J; Ma J; Zhou H; Pan J; Tan Y; Chen S; Xu G; Wang G
Parkinsonism Relat Disord; 2018 Oct; 55():75-80. PubMed ID: 29802079
[TBL] [Abstract][Full Text] [Related]
2. Mortality in Parkinson's disease: a 38-year follow-up study.
Pinter B; Diem-Zangerl A; Wenning GK; Scherfler C; Oberaigner W; Seppi K; Poewe W
Mov Disord; 2015 Feb; 30(2):266-9. PubMed ID: 25447933
[TBL] [Abstract][Full Text] [Related]
3. Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.
Wang G; Li XJ; Hu YS; Cheng Q; Wang CF; Xiao Q; Liu J; Ma JF; Zhou HY; Pan J; Tan YY; Wang Y; Chen SD
Can J Neurol Sci; 2015 Jul; 42(4):242-7. PubMed ID: 26153040
[TBL] [Abstract][Full Text] [Related]
4. Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China.
Wang S; Li T; Zhou T; Pu L; Wang HY; Yin X; Hao X; Ren L; Liang Z
BMC Neurol; 2022 Sep; 22(1):367. PubMed ID: 36138355
[TBL] [Abstract][Full Text] [Related]
5. Mortality of Alzheimer's Disease Patients: A 10-Year Follow-up Pilot Study in Shanghai.
Zhang YQ; Wang CF; Xu G; Zhao QH; Xie XY; Cui HL; Wang Y; Ren RJ; Guo QH; Wang G
Can J Neurol Sci; 2020 Mar; 47(2):226-230. PubMed ID: 31806074
[TBL] [Abstract][Full Text] [Related]
6. Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients.
Auyeung M; Tsoi TH; Mok V; Cheung CM; Lee CN; Li R; Yeung E
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):607-11. PubMed ID: 22362919
[TBL] [Abstract][Full Text] [Related]
7. The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.
Peretz C; Rozani V; Giladi N; El-Ad B; Tsamir J; Hemo B; Gurevich T
Neuroepidemiology; 2019; 53(1-2):13-19. PubMed ID: 31203291
[TBL] [Abstract][Full Text] [Related]
8. Mortality in Parkinson's disease: a 20-year follow-up study.
Diem-Zangerl A; Seppi K; Wenning GK; Trinka E; Ransmayr G; Oberaigner W; Poewe W
Mov Disord; 2009 Apr; 24(6):819-25. PubMed ID: 19224612
[TBL] [Abstract][Full Text] [Related]
9. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.
Hely MA; Morris JG; Traficante R; Reid WG; O'Sullivan DJ; Williamson PM
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):300-7. PubMed ID: 10449550
[TBL] [Abstract][Full Text] [Related]
10. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up).
Duarte J; García Olmos LM; Mendoza A; Clavería LE
Acta Neurol Scand; 2013 May; 127(5):295-300. PubMed ID: 22957805
[TBL] [Abstract][Full Text] [Related]
11. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
[TBL] [Abstract][Full Text] [Related]
12. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.
Ben-Shlomo Y; Churchyard A; Head J; Hurwitz B; Overstall P; Ockelford J; Lees AJ
BMJ; 1998 Apr; 316(7139):1191-6. PubMed ID: 9583926
[TBL] [Abstract][Full Text] [Related]
13. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population.
Hobson P; Meara J; Ishihara-Paul L
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1093-8. PubMed ID: 20571039
[TBL] [Abstract][Full Text] [Related]
14. Motor and non-motor function predictors of mortality in Parkinson's disease.
Bugalho P; Ladeira F; Barbosa R; Marto JP; Borbinha C; Salavisa M; da Conceição L; Saraiva M; Fernandes M; Meira B
J Neural Transm (Vienna); 2019 Nov; 126(11):1409-1415. PubMed ID: 31385098
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
[TBL] [Abstract][Full Text] [Related]
16. A 12-year population-based study of freezing of gait in Parkinson's disease.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Parkinsonism Relat Disord; 2015 Mar; 21(3):254-8. PubMed ID: 25603767
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Mortality of Parkinson's Disease in Estonia.
Kadastik-Eerme L; Taba N; Asser T; Taba P
Neuroepidemiology; 2019; 53(1-2):63-72. PubMed ID: 30991384
[TBL] [Abstract][Full Text] [Related]
18. Mortality and Parkinson disease: A community based study.
Herlofson K; Lie SA; Arsland D; Larsen JP
Neurology; 2004 Mar; 62(6):937-42. PubMed ID: 15037696
[TBL] [Abstract][Full Text] [Related]
19. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs.
Raschetti R; Spila-Alegiani S; Vanacore N; Ancona C; Meco G
Acta Neurol Scand; 1998 Jan; 97(1):20-6. PubMed ID: 9482674
[TBL] [Abstract][Full Text] [Related]
20. How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Tanner C; Marek K;
Parkinsonism Relat Disord; 2016 Jul; 28():62-7. PubMed ID: 27132498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
